Shi Xiangyu,Wang Ping,Zhang Wencheng,et al.Prognostic value of postoperative radiotherapy for locally advanced pulmonary adenocarcinoma with micropapillary pattern[J].Chinese Journal of Radiological Medicine and Protection,2015,35(12):910-915
Prognostic value of postoperative radiotherapy for locally advanced pulmonary adenocarcinoma with micropapillary pattern
Received:June 09, 2015  
DOI:10.3760/cma.j.issn.0254-5098.2015.12.006
KeyWords:Non-small cell lung cancer  Micropapillary  Radiotherapy  Prognosis
FundProject:国家自然科学基金(81372518);天津市抗癌重大专项攻关计划项目(12ZCDZSY15900)
Author NameAffiliationE-mail
Shi Xiangyu 300060 天津医科大学肿瘤医院放疗科 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室  
Wang Ping 300060 天津医科大学肿瘤医院放疗科 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室  
Zhang Wencheng 300060 天津医科大学肿瘤医院放疗科 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室  
Su Yanjun 300060 天津医科大学肿瘤医院肺部肿瘤科  
Zhao Lujun 300060 天津医科大学肿瘤医院放疗科 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室  
Wang Jun 300060 天津医科大学肿瘤医院放疗科 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室  
Pang Qingsong 300060 天津医科大学肿瘤医院放疗科 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室 pangqingsong2013@163.com 
Hits: 3573
Download times: 3290
Abstract::
      Objective To investigate the prognostic significance of postoperative radiotherapy (PORT) for locally advanced pulmonary adenocarcinoma with micropapillary pattern(MPPAC). MethodsA total of 45 completely resected pN2-3 cases that occured from January 2012 to December 2014 at Tianjin Medical University Cancer Hospital were retrospectively analyzed. All of them were diagnosed with MPPAC by pathological diagnosis. Based on whether receiving PORT, patients were divided into radiotherapy and non-radiotherapy groups. General characteristics, overall survival and disease-free survival characteristics of the two groups were compared, respectively. Results The median overall survival (OS) of patients was 19.8 months, 1-year and 2-year overall survival rate was 79.4% and 30.3%, respectively. The median disease free survival (DFS) of patients was 13 months, 1-year and 2-year, and the disease free survival rate was 59.3% and 28.9%, respectively. The radiotherapy and non-radiotherapy groups exhibited median OS of 22.3 and 11.4 months, respectively(χ2=13.329,P<0.05), and corresponding DFS of 16.2 and 10.4 months(χ2=7.972,P<0.05).The epidermal growth factor receptor gene (EGFR) mutation rate of patients was 57.14%(20/35), In the subgroup analysis, for patients with EGFR mutation, the radiotherapy and non-radiotherapy groups showed median OS of 25.6 and 18.4 months, respectively(χ2=9.268,P<0.05), and corresponding DFS of 21.6 and 12.6 months(P>0.05). For patients with wild-type EGFR, the radiotherapy and non-radiotherapy groups showed median OS of 21.8 and 10.6 months, respectively(χ2=9.595,P<0.05), and corresponding DFS of 15.2 and 6.6 months(χ2=4.538,P<0.05). Conclusions PORT could improve survival of patients with pN2-3 MPPAC. For patients with locally advanced MPPAC after curative resection, PORT is still an integral part of treatment.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:11566331  On-line:0

v
Scan QR Code
&et=B172190E08D194BB7A72C6B4CD06A48B9CDA60090C567552D0EE3E9E142806F73B487A00A8EA113F0805739F3A9E54030104DDF058FE29776058197A81D88FBE180E2D4E92878B2E86909F1D31E8A4AE99723F5356D367E217687487E5CEE27CC20B74274A87153468C0C1C111CA2AA72E1D0CAA10462C3B7B11659A09BFB94A&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=FFD10F7019FAA9EC&aid=66A5F5CACC9A162325801DCA8D1FDB9B&vid=&iid=59906B3B2830C2C5&sid=A02B0E6E62BE4F0C&eid=BD77137A0285B6FF&fileno=20151206&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="FFD10F7019FAA9EC"; var my_aid="66A5F5CACC9A162325801DCA8D1FDB9B";